In the absence of a screening programme and ongoing ad hoc PSA testing in the United Kingdom, our findings give indications to the natural history of prostate cancer and have implications for design of demonstration projects and research studies, pending the results from randomised controlled screening trials. Here, KLK3 is linked to prostate cancer.